SRX3207 is a novel dual PI3K-Syk inhibitor with IC50 of 244 nM, 388 nM, 9790 nM, 39.9 nM, 31200 nM, 3070 nM, 3070 nM for PI3K alpha, PI3K delta, PI3K gamma, Syk, Zap70, BRD41, BRD42, respectively. SRX3207 can relieve tumor immunosuppression.

2254693-15-5

C29H29N7O3S

555.65

SRX3207

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years